Ballantyne CM - Search Results

1

The impact of rapid weight loss on oxidative stress markers and the expression of the metabolic syndrome in obese individuals.

Tumova E, Sun W, Jones PH, Vrablik M, Ballantyne CM, Hoogeveen RC. Tumova E, et al. Among authors: ballantyne cm. J Obes. 2013;2013:729515. doi: 10.1155/2013/729515. Epub 2013 Dec 19. J Obes. 2013. PMID: 24455214 Free PMC article.

2

Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendations.

Ballantyne CM, Radovancevic B, Farmer JA, Frazier OH, Chandler L, Payton-Ross C, Cocanougher B, Jones PH, Young JB, Gotto AM Jr. Ballantyne CM, et al. J Am Coll Cardiol. 1992 May;19(6):1315-21. doi: 10.1016/0735-1097(92)90340-s. J Am Coll Cardiol. 1992. PMID: 1564233 Free article.

3

Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS]).

Herd JA, Ballantyne CM, Farmer JA, Ferguson JJ 3rd, Jones PH, West MS, Gould KL, Gotto AM Jr. Herd JA, et al. Among authors: ballantyne cm. Am J Cardiol. 1997 Aug 1;80(3):278-86. doi: 10.1016/s0002-9149(97)00346-9. Am J Cardiol. 1997. PMID: 9264419 Clinical Trial.

4

Effects of lipid lowering therapy on progression of coronary and carotid artery disease.

Ballantyne CM, Herd JA, Dunn JK, Jones PH, Farmer JA, Gotto AM Jr. Ballantyne CM, et al. Curr Opin Lipidol. 1997 Dec;8(6):354-61. doi: 10.1097/00041433-199712000-00006. Curr Opin Lipidol. 1997. PMID: 9412776 Review.

5

Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy.

Ballantyne CM, Herd JA, Ferlic LL, Dunn JK, Farmer JA, Jones PH, Schein JR, Gotto AM Jr. Ballantyne CM, et al. Circulation. 1999 Feb 16;99(6):736-43. doi: 10.1161/01.cir.99.6.736. Circulation. 1999. PMID: 9989957 Clinical Trial.

6

Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patients.

Hoogeveen RC, Ballantyne CM, Pownall HJ, Opekun AR, Hachey DL, Jaffe JS, Oppermann S, Kahan BD, Morrisett JD. Hoogeveen RC, et al. Among authors: ballantyne cm. Transplantation. 2001 Oct 15;72(7):1244-50. doi: 10.1097/00007890-200110150-00011. Transplantation. 2001. PMID: 11602850

7

Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.

Morrisett JD, Abdel-Fattah G, Hoogeveen R, Mitchell E, Ballantyne CM, Pownall HJ, Opekun AR, Jaffe JS, Oppermann S, Kahan BD. Morrisett JD, et al. Among authors: ballantyne cm. J Lipid Res. 2002 Aug;43(8):1170-80. J Lipid Res. 2002. PMID: 12177161 Free article.

8

Impact of weight loss on the metabolic syndrome.

Case CC, Jones PH, Nelson K, O'Brian Smith E, Ballantyne CM. Case CC, et al. Among authors: ballantyne cm. Diabetes Obes Metab. 2002 Nov;4(6):407-14. doi: 10.1046/j.1463-1326.2002.00236.x. Diabetes Obes Metab. 2002. PMID: 12406040

9

Efficacy of rosuvastatin 10 mg in patients with the metabolic syndrome.

Ballantyne CM, Stein EA, Paoletti R, Southworth H, Blasetto JW. Ballantyne CM, et al. Am J Cardiol. 2003 Mar 6;91(5A):25C-27C; discussion 28C. doi: 10.1016/s0002-9149(03)00006-7. Am J Cardiol. 2003. PMID: 12646342 Clinical Trial.

10

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study.

Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G; Atherosclerosis Risk in Communities Study. Duncan BB, et al. Among authors: ballantyne cm. Diabetes. 2003 Jul;52(7):1799-805. doi: 10.2337/diabetes.52.7.1799. Diabetes. 2003. PMID: 12829649

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,054 results

Search Page

Filters